Ledger.Open graph →
SEC Form D · filed March 27, 2024

Skye Bioscience, Inc

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Paul Grayson · San Diego, CADirectorDeborah Charych · San Diego, CADirectorMargaret Dalesandro · San Diego, CADirectorKaitlyn Arsenault · San Diego, CAExecPunit Dhillon · San Diego, CAExec · DirectorKeith Ward · San Diego, CADirectorAndrew Schwab · San Diego, CADirectorPraveen Tyle · San Diego, CADirectorKeith Ward · San Diego, CADirectorAndrew Schwab · San Diego, CADirectorMargaret Dalesandro · San Diego, CADirectorPunit Dhillon · San Diego, CAExec · DirectorPaul Grayson · San Diego, CADirectorDeborah Charych · San Diego, CADirectorPraveen Tyle · San Diego, CADirectorKaitlyn Arsenault · San Diego, CAExecAnnalisa Jenkins · Leiden, P7DirectorMC Credit Associates SN LP · Stamford, CTDirectorCharles M. Pickrell · NASHVILLE, TNExecRichard D. Hendrick · NASHVILLE, TNDirectorS. D. Herrell · NASHVILLE, TNDirectorOlibia Stamatoglou · CHICAGO, ILExec · DirectorJohn Martin · CHICAGO, ILDirectorCourant Investment Management LLC · Franklin, TNDirectorClaude Leveille · Franklin, TNDirectorAnnalisa Jenkins · Leiden, P7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗